The Pharma ADMET Testing Global Market Report 2023, provides comprehensive information on the pharma ADMET testing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Pharma ADMET Testing Market’s Growth:
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report
As per The Business Research Company’s Pharma ADMET Testing Global Market Report 2023, the market size is expected to grow from $7.71 billion in 2022 to $8.62 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pharma ADMET testing market is expected to reach $13.1 billion in 2027 at a CAGR of 11.2%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12024&type=smp
Product innovations are a key trend gaining popularity in the pharma ADMET testing market. Major companies in the pharma ADMET testing market are introducing innovative products such as Logica to sustain their position in the market. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, and Valo Health Inc., a US-based AI-health solution company, launched Logica, an AI-based drug development solution. The new solution leverages Valo’s AI-powered Opal Computational Platform to provide users with ADMET testing services and other drug delivery solutions. Logi¬ca makes use of industry-leading predictive models, chem¬i¬cal design and syn¬the¬sis capabil¬i-ties, DNA-encod¬ed libraries, and in sil¬i¬co high through¬put screen¬ing from Valo’s Opal Com¬pu¬ta¬tion¬al Plat-form, in addition to the Charles River’s lead¬ing capa¬bil¬i¬ties in all aspects of dis¬cov¬ery opti¬miza¬tion includ¬ing high through¬put screen¬ing, med¬i¬c¬i¬nal chem¬istry, ADME, biol¬o¬gy, phar¬ma¬col¬o¬gy, and ulti¬mate¬ly safe¬ty test-ing and IND sub¬mis¬sion
The pharma ADMET testing market is segmented:
1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing
2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology
3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications
Asia-Pacific was the largest region in the pharma ADMET testing market in 2022.
The table of contents in TBRC’s pharma ADMET testing market report includes:
1. Executive Summary
2. Pharma ADMET Testing Market Characteristics
3. Pharma ADMET Testing Market Trends And Strategies
4. Pharma ADMET Testing Market – Macro Economic Scenario
5. Pharma ADMET Testing Market Segmentation
.
.
.
26. South America Pharma ADMET Testing Market
27. Brazil Pharma ADMET Testing Market
28. Middle East Pharma ADMET Testing Market
29. Africa Pharma ADMET Testing Market
30. Pharma ADMET Testing Market Competitive Landscape And Company Profiles
Top Major Players:
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- The Merck Group
- Laboratory Corporation of America Holdings
- IQVIA Inc
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model